PDCD1 and malignant colon neoplasm: Imaging allowed to track fluorescently labeled anti-PD-1 mAb in a mouse model of colon cancer and identified the removal of anti-PD-1 mAbs from its target T cells in a Fc receptor-dependent process by tumor-associated macrophages as unexpected resistance mechanism [68].